Provided by Tiger Trade Technology Pte. Ltd.

TG Therapeutics

55.85
+2.815.30%
Post-market: 55.75-0.1000-0.18%19:52 EDT
Volume:2.35M
Turnover:131.24M
Market Cap:8.55B
PE:20.17
High:57.61
Open:53.12
Low:53.11
Close:53.04
52wk High:59.30
52wk Low:26.76
Shares:153.09M
Float Shares:141.54M
Volume Ratio:1.62
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):2.77
ROE:100.28%
ROA:7.28%
PB:14.15
PE(LYR):20.16

Loading ...

Palvella Therapeutics Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 04

Switzerland's Crispr Therapeutics Q2 Casgevy Revenue Jumps 151%, Net Loss Narrows on FDA Approval for Expansion

Reuters
·
Aug 04

Stoke Therapeutics Q2 Revenue Falls 33% on Lower Collaboration, Licensing Income

Reuters
·
Aug 04

TG Therapeutics Down over 11%, on Pace for Largest Percent Decrease Since August 2025

Dow Jones
·
Aug 04

TG Therapeutics falls -10.6%

TIPRANKS
·
Aug 04

Movement Alert|TG Therapeutics Falls 5.35% in Regular Trading, Q2 EPS Misses Estimates by 85%

Market Focus
·
Aug 03

Stock Track | TG Therapeutics Plummets 7% in Intraday Trading After Q2 Earnings Miss Overshadows Strong Revenue and Raised Guidance

Stock Track
·
Aug 03

TG Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 03

Design Therapeutics Q2 Net Loss Narrower than Expected

Reuters
·
Aug 03

Movement Alert|TG Therapeutics Falls 5.37% in Pre-Market Trading, Q2 EPS Misses Estimates by 85%

Market Focus
·
Aug 03

Stock Track | TG Therapeutics (TGTX) Plunges 5.37% in Pre-market After Q2 Earnings Miss, Despite Strong Revenue and Raised Guidance

Stock Track
·
Aug 03

Ocular Therapeutix Q2 Product Revenue Flat, Net Loss Widens on Higher Spending

Reuters
·
Aug 03

TG Therapeutics Q2 Product Revenue Rises 70% on Briumvi Sales

Reuters
·
Aug 03

Earnings Flash (TGTX) TG Therapeutics Posts Q2 EPS $0.05, vs. FactSet Est of $0.31

MT Newswires Live
·
Aug 03

TG Therapeutics Q2 Net Income Drops to $7.8 Million; Revenue Rises 70.26% to $240.3 Million

Reuters
·
Aug 03

TG Therapeutics Q2 EPS $0.05 Misses $0.33 Estimate, Sales $240.335M Beat $229.721M Estimate

Benzinga Earnings
·
Aug 03

TG Therapeutics Q2 EPS USD 0.05

THOMSON REUTERS
·
Aug 03

TG Therapeutics - Raises FY 2026 Total Global Revenue Target to About $950 Mln

THOMSON REUTERS
·
Aug 03

TG Therapeutics Q2 Operating Income USD 21.674 Million

THOMSON REUTERS
·
Aug 03

TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

GlobeNewswire
·
Aug 03